Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Nephrotic syndrome, type 21"
Page 1
Interventions for focal segmental glomerulosclerosis in adults.
Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD003233. doi: 10.1002/14651858.CD003233.pub3.
Cochrane Database Syst Rev. 2022.
PMID: 35224732
Free PMC article.
Review.
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) can be separated into primary, genetic or secondary causes. Primary disease results in nephrotic syndrome while genetic and secondary forms may be associated with asymptomatic proteinuria or with nephrotic …
BACKGROUND: Focal segmental glomerulosclerosis (FSGS) can be separated into primary, genetic or secondary causes. Primary disease results in …
Sphingosine phosphate lyase insufficiency syndrome: a systematic review.
Pournasiri Z, Madani A, Nazarpack F, Sayer JA, Chavoshzadeh Z, Nili F, Tran P, Saba JD, Jamee M.
Pournasiri Z, et al.
World J Pediatr. 2023 May;19(5):425-437. doi: 10.1007/s12519-022-00615-4. Epub 2022 Nov 12.
World J Pediatr. 2023.
PMID: 36371483
Review.
BACKGROUND: Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) or nephrotic syndrome type-14 is caused by biallelic mutations in SGPL1. ...Kidney disorders (42, 80.8%) were mainly in the form of steroid-resistant nephrotic syndrome …
BACKGROUND: Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) or nephrotic syndrome type-14 is caused …
Item in Clipboard
Bevacizumab increases risk for severe proteinuria in cancer patients.
Wu S, Kim C, Baer L, Zhu X.
Wu S, et al.
J Am Soc Nephrol. 2010 Aug;21(8):1381-9. doi: 10.1681/ASN.2010020167. Epub 2010 Jun 10.
J Am Soc Nephrol. 2010.
PMID: 20538785
Free PMC article.
Review.
Compared with chemotherapy alone, bevacizumab combined with chemotherapy significantly increased the risk for high-grade proteinuria (relative risk 4.79; 95% CI 2.71 to 8.46) and nephrotic syndrome (relative risk 7.78; 95% CI 1.80 to 33.62); higher dosages of bevaci …
Compared with chemotherapy alone, bevacizumab combined with chemotherapy significantly increased the risk for high-grade proteinuria (relati …
Item in Clipboard
Cite
Cite